OBJECTIVES: Our goal was to assess the effect of hypercoagulability on the risk of stroke in patients with aortic plaques. BACKGROUND: Atherosclerotic plaques in the aortic arch are a risk factor for ischemic stroke. Their relationship with blood hypercoagulability, which might enhance their embolic potential and affect treatment and prevention, is not known. METHODS: We performed transesophageal echocardiography in 255 patients with first acute ischemic stroke and in 209 control subjects matched by age, gender, and race/ethnicity. The association between arch plaques and hypercoagulability, and its effect on the stroke risk, was assessed with a case-control design. Stroke patients were then followed prospectively to assess recurrent stroke and death. RESULTS: Large (> or =4 mm) arch plaques were associated with increased stroke risk (adjusted odds ratio [OR]: 2.4, 95% confidence interval [CI]: 1.3 to 4.6), especially when ulcerations or superimposed thrombus were present (adjusted OR: 3.3, 95% CI: 1.4 to 8.2). Prothrombin fragment F 1.2, an indicator of thrombin generation, was associated with large plaques in stroke patients (p = 0.02), but not in control subjects. Over a mean follow-up of 55.1 +/- 37.2 months, stroke patients with large plaques and F 1.2 over the median value had a significantly higher risk of recurrent stroke and death than those with large plaques but lower F 1.2 levels (230 events per 1,000 person-years vs. 85 events per 1,000 person-years; p = 0.05). CONCLUSIONS: In patients presenting with acute ischemic stroke, large aortic plaques are associated with blood hypercoagulability, suggesting a role for coagulation activation in the stroke mechanism. Coexistence of large aortic plaques and blood hypercoagulability is associated with an increased risk of recurrent stroke and death.
OBJECTIVES: Our goal was to assess the effect of hypercoagulability on the risk of stroke in patients with aortic plaques. BACKGROUND:Atherosclerotic plaques in the aortic arch are a risk factor for ischemic stroke. Their relationship with blood hypercoagulability, which might enhance their embolic potential and affect treatment and prevention, is not known. METHODS: We performed transesophageal echocardiography in 255 patients with first acute ischemic stroke and in 209 control subjects matched by age, gender, and race/ethnicity. The association between arch plaques and hypercoagulability, and its effect on the stroke risk, was assessed with a case-control design. Strokepatients were then followed prospectively to assess recurrent stroke and death. RESULTS: Large (> or =4 mm) arch plaques were associated with increased stroke risk (adjusted odds ratio [OR]: 2.4, 95% confidence interval [CI]: 1.3 to 4.6), especially when ulcerations or superimposed thrombus were present (adjusted OR: 3.3, 95% CI: 1.4 to 8.2). Prothrombin fragment F 1.2, an indicator of thrombin generation, was associated with large plaques in strokepatients (p = 0.02), but not in control subjects. Over a mean follow-up of 55.1 +/- 37.2 months, strokepatients with large plaques and F 1.2 over the median value had a significantly higher risk of recurrent stroke and death than those with large plaques but lower F 1.2 levels (230 events per 1,000 person-years vs. 85 events per 1,000 person-years; p = 0.05). CONCLUSIONS: In patients presenting with acute ischemic stroke, large aortic plaques are associated with blood hypercoagulability, suggesting a role for coagulation activation in the stroke mechanism. Coexistence of large aortic plaques and blood hypercoagulability is associated with an increased risk of recurrent stroke and death.
Authors: Yoram Agmon; Bijoy K Khandheria; Irene Meissner; Gary L Schwartz; Tanya M Petterson; W Michael O'Fallon; Jack P Whisnant; David O Wiebers; James B Seward Journal: Am J Cardiol Date: 2002-02-01 Impact factor: 2.778
Authors: Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Atherosclerosis Date: 2011-08-16 Impact factor: 5.162
Authors: Shinichi Iwata; Zhezhen Jin; Joseph E Schwartz; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Ralph L Sacco; Marco R Di Tullio Journal: Atherosclerosis Date: 2012-01-10 Impact factor: 5.162
Authors: Inna F Bukharovich; Omar Wever-Pinzon; Ajay Shah; George Todd; Farooq A Chaudhry; Mark V Sherrid Journal: Echocardiography Date: 2011-12-09 Impact factor: 1.724
Authors: Aylin Tugcu; Kazue Okajima; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Mitchell S V Elkind; Marco R Di Tullio Journal: JACC Cardiovasc Imaging Date: 2010-12
Authors: Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Int J Stroke Date: 2010-08 Impact factor: 5.266
Authors: Cesare Russo; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio Journal: Stroke Date: 2009-06-04 Impact factor: 7.914
Authors: Marco R Di Tullio; Cesare Russo; Zhezhen Jin; Ralph L Sacco; J P Mohr; Shunichi Homma Journal: Circulation Date: 2009-04-20 Impact factor: 29.690
Authors: Benjamin S Wessler; David E Thaler; Robin Ruthazer; Christian Weimar; Marco R Di Tullio; Mitchell S V Elkind; Shunichi Homma; Jennifer S Lutz; Jean-Louis Mas; Heinrich P Mattle; Bernhard Meier; Krassen Nedeltchev; Federica Papetti; Emanuele Di Angelantonio; Mark Reisman; Joaquín Serena; David M Kent Journal: Circ Cardiovasc Imaging Date: 2013-11-08 Impact factor: 7.792
Authors: David E Thaler; Emanuele Di Angelantonio; Marco R Di Tullio; Jennifer S Donovan; John Griffith; Shunichi Homma; Cheryl Jaigobin; Jean-Louis Mas; Heinrich P Mattle; Patrik Michel; Marie-Luise Mono; Krassen Nedeltchev; Federica Papetti; Robin Ruthazer; Joaquín Serena; Christian Weimar; Mitchell S V Elkind; David M Kent Journal: Int J Stroke Date: 2012-08-09 Impact factor: 5.266